# Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis

> **NCT00512096** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Penile Cancer

## Interventions

- **DRUG:** Ifosfamide
- **DRUG:** Paclitaxel (Taxol)
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00512096
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00512096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00512096, "Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00512096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*